CN101804187A - Chinese traditional medicine composition for treating chronic ischemic cerebrovascular disease - Google Patents

Chinese traditional medicine composition for treating chronic ischemic cerebrovascular disease Download PDF

Info

Publication number
CN101804187A
CN101804187A CN201010143880A CN201010143880A CN101804187A CN 101804187 A CN101804187 A CN 101804187A CN 201010143880 A CN201010143880 A CN 201010143880A CN 201010143880 A CN201010143880 A CN 201010143880A CN 101804187 A CN101804187 A CN 101804187A
Authority
CN
China
Prior art keywords
branch
minutes
cerebrovascular disease
ischemic cerebrovascular
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201010143880A
Other languages
Chinese (zh)
Other versions
CN101804187B (en
Inventor
王陆阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201010143880XA priority Critical patent/CN101804187B/en
Publication of CN101804187A publication Critical patent/CN101804187A/en
Application granted granted Critical
Publication of CN101804187B publication Critical patent/CN101804187B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a Chinese traditional medicine composition for treating chronic ischemic cerebrovascular disease. Aimed at the root cause of the development of the ischemic cerebrovascular disease, the invention chooses Chinese herbal medicines with the effects of tonifying Qi and invigorating the circulation of blood, dredging channels and collaterals and tonifying the liver and the spleen, including cassia twig, Chinese thorowax root, astragalus root, campanumaea pilosula, loranthus parasiticus, earthworm, drug sweetflag rhizome, dragon's teeth, sea-ear shell, dried ginger and akebia stem, which are scientifically prepared into the Chinese traditional medicine preparation which has a good curative effect on the chronic ischemic cerebrovascular disease and dos not have toxic side effect, so the Chinese traditional medicine composition is worth clinical popularization and application.

Description

A kind of Chinese medicine composition for the treatment of chronic ischemic cerebrovascular disease
Technical field
The present invention relates to a kind of Chinese medicine composition, especially relate to a kind of Chinese medicine composition for the treatment of chronic ischemic cerebrovascular disease.
Background technology
Ischemic cerebrovascular is a kind of commonly encountered diseases clinically, is meant because the cerebrovascular that a variety of causes causes stops up, and causes the cerebrovascular function obstacle, causes related symptoms, as hemiplegia, dysphonia, dizziness and tinnitus etc.At present, the treatment ischemic cerebrovascular removes rational diet, suitably takes exercise, discontinues the habit of smoking and drinking, when forming good life style, generally carry out Drug therapy, at present, it is more to treat this sick medicine, but the ubiquity therapeutic effect is poor, and the medicine that has is taken for a long time, and side effect is big.
Summary of the invention
Purpose of the present invention is exactly the root that forms at ischemic cerebrovascular, selection has the middle medicinal herbs of benefiting QI for activating blood circulation, collateral dredging passages through which vital energy circulates, tonifying liver spleen invigorating, through the science compatibility, that makes is a kind of good to the chronic ischemic cerebrovascular disease therapeutic effect, the Chinese medicine preparation that has no side effect.
The objective of the invention is to be achieved through the following technical solutions, the Chinese medicine composition of this treatment chronic ischemic cerebrovascular disease is made up of the crude drug of following weight fraction: Ramulus Cinnamomi 10-15 branch, Radix Bupleuri 10-15 branch, Radix Astragali 10-15 branch, Radix Codonopsis 5-10 branch, Herba Taxilli 5-10 branch, Pheretima 3-6 branch, Rhizoma Acori Graminei 3-6 branch, Dens Draconis 5-10 branch, Concha Haliotidis 3-6 branch, Rhizoma Zingiberis 10-15 branch, Caulis Akebiae 3-6 branch.
The crude drug that the Chinese medicine composition of this treatment chronic ischemic cerebrovascular disease is divided by following optimum weight is formed: Ramulus Cinnamomi 12 minutes, Radix Bupleuri 12 minutes, the Radix Astragali 13 minutes, Radix Codonopsis 8 minutes, Herba Taxilli 8 minutes, Pheretima 5 minutes, Rhizoma Acori Graminei 5 minutes, Dens Draconis 7 minutes, Concha Haliotidis 4 minutes, Rhizoma Zingiberis 13 minutes, Caulis Akebiae 4 minutes.
Preparation method: with above Chinese medicine routinely preparation method can be made into various dosage forms, as capsule, decoction etc.
In the side: Ramulus Cinnamomi promoting the flow of QI-blood by warming the meridian, activating YANG and prormoting functioning of QI; The Radix Codonopsis invigorating the spleen and replenishing QI, the spleen invigorating lung benefiting; The Radix Bupleuri reconciling superficies and interior, soothing the liver yang invigorating; Herba Taxilli: invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling; The Pheretima meridians that pass through; Rhizoma Acori Graminei is warded off and dirtyly has one's ideas straightened out, and controls anemofrigid-damp arthralgia; Throb with fear and calm the nerves in the Dens Draconis town, heat clearing away and restlessness relieving; The Concha Haliotidis suppressing the hyperactive liver to relieve the wind syndrome, YANG hyperactivity suppressing has hepatoprotective effect and significant anticoagulation; The Rhizoma Zingiberis warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, warming the lung to resolve fluid-retention; Caulis Akebiae pathogenic fire purging row, promoting blood circulation.
Clinical data
1, inclusion criteria: 1. the acute cerebrovascular disease history of attack is arranged, but do not have the performance of local nerve afunction near at least half a year; 2. have because the clinical symptoms of limitation or diffusivity nervous lesion; 3. nervus centralis funtion part, mild damage; 5. treatment there are enough compliances.
2, physical data: this is organized 206 routine patients and all meets above-mentioned standard.The main clinical manifestation of listing observation in has dizziness, headache, tinnitus, attention undiscipline, forgetful etc.Neuropsychological test adopts the scoring of simple intelligent status checkout scale.206 routine patients are divided into two groups at random.106 examples are organized in treatment, wherein male 76 examples, women 30 examples, 46 years old one 77 years old age, average 56.5 years old ± 16.2 years old, MMSE scoring 21.9 ± 8.1; Matched group 100 examples, wherein male 72 examples, women 28 examples, 48 years old one 78 years old age, average 58.9 years old ± 15.2 years old, MMSE scoring 22.0 ± 7.7.The processing there was no significant difference is learned in two groups of patient's physical data and clinical manifestation by statistics, sees Table 1.
Table 1 liang group patient's physical data and clinical manifestation situation
Figure GSA00000059029100021
3, Therapeutic Method
Oral capsule of the present invention is organized in treatment, 60mg, 2 times/day, totally 8 weeks.The oral nimodipine sustained release capsules of matched group, 60mg, 2 times/day, totally 8 weeks.Blood test respectively, routine urinalysis and liver, renal function before and after all patient treatments.Write down untoward reaction simultaneously.
4, curative effect is judged
Produce effects: clinical symptom relief 80% one 96%; Effectively: clinical symptom relief 50% one 79%; Progressive: clinical symptom relief 30% one 49%; Invalid: clinical symptom relief less than 30%, increase the weight of or treat during have acute neurological deficit incident to take place.
5, statistical method
Data represents that with ± s statistical method adopts t check in groups, paired t-test) (2 checks and Ridit analyze etc.
6, therapeutic effect
Treatment group total effective rate is 90.6%, and the matched group total effective rate is 66%.Two groups of curative effects have significant differences (P<0.01), see Table 2.The average MMSE scoring in treatment group treatment back obviously improves (P<0.01) before the treatment, and average MMSE scoring also has raising (P<0.05) before the treatment after the treatment of control group.Two groups of average MMSE scorings in treatment back are compared, and the treatment group sees Table 3 apparently higher than matched group (P<0.01).Blood test behind two groups of patient treatments, urinalysis and liver, all no abnormal discovery of renal function.It is dizzy, nauseating that the treatment group has 5 examples to occur during medication, about 2 weeks back disappearance, and influence is treated.Dizzy, 6 examples of feeling sick that matched group occurs, flush, each 4 example of skin pruritus.
Clinical manifestation relatively behind the table 2 liang group patient treatment
Group The example number Produce effects Effectively Progressive Invalid The R value
The treatment group ??106 ??46 ??40 ??10 ??10 ??0.3985
Matched group ??100 ??18 ??28 ??20 ??34 ??0.6076
Annotate: two groups of treatment back mdit analyze P<0.01
Average MMSE scoring relatively before and after the table 3 liang group patient treatment
Time The treatment group Matched group
Before the treatment ??21.9±8.1 ??22.0±7.7
After the treatment ??25.6±3.7 ??23.2±6.7
Annotate: with preceding relatively P<0.01 of matched group that reaches of treatment; With preceding relatively P<0.05 of treatment
The specific embodiment
Embodiment one: get Ramulus Cinnamomi 120 grams, Radix Bupleuri 120 grams, the Radix Astragali 130 grams, Radix Codonopsis 80 grams, Herba Taxilli 80 grams, Pheretima 50 grams, Rhizoma Acori Graminei 50 grams, Dens Draconis 70 grams, Concha Haliotidis 40 grams, Rhizoma Zingiberis 130 grams, Caulis Akebiae 40 grams.Pulverize separately, mix homogeneously incapsulates and gets final product.
Embodiment two: get Ramulus Cinnamomi 150 grams, Radix Bupleuri 100 grams, the Radix Astragali 100 grams, Radix Codonopsis 100 grams, Herba Taxilli 100 grams, Pheretima 30 grams, Rhizoma Acori Graminei 30 grams, Dens Draconis 100 grams, Concha Haliotidis 60 grams, Rhizoma Zingiberis 150 grams, Caulis Akebiae 30 grams.Pulverize separately, mix homogeneously incapsulates and gets final product.
Embodiment three: get Ramulus Cinnamomi 100 grams, Radix Bupleuri 150 grams, the Radix Astragali 150 grams, Radix Codonopsis 50 grams, Herba Taxilli 50 grams, Pheretima 60 grams, Rhizoma Acori Graminei 60 grams, Dens Draconis 50 grams, Concha Haliotidis 30 grams, Rhizoma Zingiberis 100 grams, Caulis Akebiae 60 grams.Pulverize separately, mix homogeneously incapsulates and gets final product.

Claims (2)

1. Chinese medicine composition for the treatment of chronic ischemic cerebrovascular disease, the Chinese medicine composition that it is characterized in that this treatment chronic ischemic cerebrovascular disease is made up of the crude drug of following weight fraction: Ramulus Cinnamomi 10-15 branch, Radix Bupleuri 10-15 branch, Radix Astragali 10-15 branch, Radix Codonopsis 5-10 branch, Herba Taxilli 5-10 branch, Pheretima 3-6 branch, Rhizoma Acori Graminei 3-6 branch, Dens Draconis 5-10 branch, Concha Haliotidis 3-6 branch, Rhizoma Zingiberis 10-15 branch, Caulis Akebiae 3-6 branch.
2. a kind of Chinese medicine composition for the treatment of chronic ischemic cerebrovascular disease according to claim 1, the Chinese medicine composition that it is characterized in that this treatment chronic ischemic cerebrovascular disease is made up of the crude drug of following optimum weight branch: Ramulus Cinnamomi 12 minutes, Radix Bupleuri 12 minutes, the Radix Astragali 13 minutes, Radix Codonopsis 8 minutes, Herba Taxilli 8 minutes, Pheretima 5 minutes, Rhizoma Acori Graminei 5 minutes, Dens Draconis 7 minutes, Concha Haliotidis 4 minutes, Rhizoma Zingiberis 13 minutes, Caulis Akebiae 4 minutes.
CN201010143880XA 2010-04-04 2010-04-04 Chinese traditional medicine composition for treating chronic ischemic cerebrovascular disease Expired - Fee Related CN101804187B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201010143880XA CN101804187B (en) 2010-04-04 2010-04-04 Chinese traditional medicine composition for treating chronic ischemic cerebrovascular disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010143880XA CN101804187B (en) 2010-04-04 2010-04-04 Chinese traditional medicine composition for treating chronic ischemic cerebrovascular disease

Publications (2)

Publication Number Publication Date
CN101804187A true CN101804187A (en) 2010-08-18
CN101804187B CN101804187B (en) 2011-08-10

Family

ID=42606247

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010143880XA Expired - Fee Related CN101804187B (en) 2010-04-04 2010-04-04 Chinese traditional medicine composition for treating chronic ischemic cerebrovascular disease

Country Status (1)

Country Link
CN (1) CN101804187B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1102784A (en) * 1994-02-28 1995-05-24 虹雨集团公司 Chinese patent medicine for prevention and control of ischemic cardio-cerebral angiopathy
CN1726972A (en) * 2004-07-31 2006-02-01 兰州佛慈制药股份有限公司 Combination of medication in use for treating coronary heart disease and preparation method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1102784A (en) * 1994-02-28 1995-05-24 虹雨集团公司 Chinese patent medicine for prevention and control of ischemic cardio-cerebral angiopathy
CN1726972A (en) * 2004-07-31 2006-02-01 兰州佛慈制药股份有限公司 Combination of medication in use for treating coronary heart disease and preparation method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
《甘肃中医》 20070228 黄邦荣等 裴正学教授治疗脑血管意外经验 第20卷, 第2期 2 *
《辽宁中医杂志》 20080718 王守富等 活血化瘀13法在心脑血管疾病中的运用 第35卷, 第7期 2 *

Also Published As

Publication number Publication date
CN101804187B (en) 2011-08-10

Similar Documents

Publication Publication Date Title
CN103007059B (en) Traditional Chinese medicine composition for treating migraine and preparation method thereof
CN102188685A (en) Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof
CN102626508B (en) Traditional Chinese medicine composite for curing liver cancer
CN101361949A (en) Traditional Chinese medicine for treating gynaecologic emmeniopathy
CN112402522B (en) Chinese herbal medicine oil for externally treating psoriasis
CN104258362A (en) Traditional Chinese medicine preparation for treating peripheral neuritis
CN101804189A (en) Drug for treating primary dysmenorrhea
CN101804187B (en) Chinese traditional medicine composition for treating chronic ischemic cerebrovascular disease
CN105233078A (en) Traditional Chinese medicine composition for treating viral hepatitis
CN101099836B (en) Traditional Chinese medicine composition for treating ischemic apoplexy and preparation process thereof
CN101057945A (en) Traditional Chinese medicine for treating digestive cancer and its producing method
CN106236857B (en) Traditional Chinese medicine composition for treating chronic renal failure and preparation method, preparation and application thereof
CN104606406B (en) A kind of traditional Chinese medicinal ointment and preparation method thereof of external application prevention of allergic rhinitis
CN103028094A (en) Chinese patent medicine for treating coronary heart disease
CN111437378B (en) Traditional Chinese medicine composition and medicine for preventing and treating chronic heart failure and preparation method thereof
CN101983712A (en) Novel medicament for treating coronary heart disease
CN101983645A (en) Medicament for treating acute appendicitis
CN110841007B (en) Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof
CN104784567B (en) A kind of pharmaceutical composition for the treatment of urinary system infection
CN105944052A (en) Traditional Chinese medicinal composition for treating cervical and lumbar diseases
CN105726849B (en) It is a kind of for treating the Chinese medicine of diabetes Depression
CN104274594B (en) One is treated prosopalgic Chinese medicine preparation
CN104758346A (en) Medicine for treating migraine, as well as preparation method and preparation of medicine
CN104645224A (en) Traditional Chinese medicine preparation for treating costal chondritis
CN112891425A (en) Traditional Chinese medicine composition for ascending the clear, descending the turbid and benefiting the spleen

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110810

Termination date: 20120404